APOA1 and AGP are acute-phase reactants, and their serum levels have been assessed in epithelial ovarian cancer to assess their potential as diagnostic or prognostic predictive biomarkers [28,29,30,31]. This evidence concerns the gene APOA1 and ovarian carcinoma.